Skip to content
University of Oxford
You are here:
Our Research
Showing posts for
Vaccine Development
Clear
Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests
22nd Feb 2021
Oxford coronavirus vaccine children's study - FAQs
15th Feb 2021
Oxford University extends COVID-19 vaccine study to children
12th Feb 2021
World Health Organization experts provide guidance on use of the Oxford vaccine
10th Feb 2021
ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults
7th Feb 2021
Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK
5th Feb 2021
Oxford leads first trial investigating dosing with alternating vaccines
4th Feb 2021
Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
2nd Feb 2021
European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine
29th Jan 2021
Oxford University vaccine developer joins day of vaccinations at the Kassam Stadium
26th Jan 2021
UK National Health Service begins rollout of Oxford coronavirus vaccine
4th Jan 2021
Oxford vaccine regulatory authorisation: FAQ
30th Dec 2020
University of Oxford welcomes regulatory authorisation of coronavirus vaccine
30th Dec 2020
Oxford vaccine stimulates broad antibody and T cell functions
17th Dec 2020
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
8th Dec 2020
Pagination
Go to page
1
Go to page
2
Go to page
3
Go to
Next
page